CXCL10 and acute respiratory distress syndrome: The expression level of CXCL10 has shown a strongly significant positive correlation with viral load and progression of COVID-19, thus it could be also used as a biomarker for COVID-19 acute respiratory distress syndrome (ARDS) patients (Oliviero et al. 2021; Hemida et al. 2010).